LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics focuses on critical issues in therapeutic drug monitorin… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomic
s focuses on critical issues in therapeutic drug monitoring including special requirements of therapeutic drug monitoring important to special populations (infants and children, pregnant women, elderly patients, and obese patients). The book also covers issues of free drug monitoring and common interferences in using immunoassays for therapeutic drug monitoring.This book is essential reading for any clinician, fellow, or trainee who wants to gain greater insight into the process of therapeutic drug monitoring for individual dosage adjustment and avoiding drug toxicity for certain drugs within a narrow therapeutic window. The book is written specifically for busy clinicians, fellows, and trainees who order therapeutic drug monitoring and need to get more familiar with testing methodologies, issues of interferences, and interpretation of results in certain patient populations.
Fellows and residents of pathology and internal medicine, practicing clinicians in pathology, family medicine and internal medicine, as well as laboratory professionals
Overview of Therapeutic Drug Monitoring
Immunoassays and Issues with Interference in Therapeutic Drug Monitoring
Application of Chromatography Combined with Mass Spectrometry in Therapeutic Drug Monitoring
Clinical Utility of Free Drug Monitoring
Therapeutic Drug Monitoring of Newer Antiepileptic Drugs
Therapeutic Drug Monitoring of Antiretrovirals
Therapeutic Drug Monitoring in Infants and Children
Therapeutic Drug Monitoring in Pregnancy
Therapeutic Drug Monitoring in the Elderly
Therapeutic Drug Monitoring in Obese Patients
Special Issues in Therapeutic Drug Monitoring in Patients with Uremia, Liver Disease, and Critically Ill Patients
Integrating Therapuetic Drug Monitoring and Pharmacogenomics
Warfarin Pharmacogenomics
Drug Monitoring in Alternative Matrices
Integrating and Supporting Therapeutic Drug Monitoring in a Hospital System
WC
AD
Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.